1. Home
  2. MAGN vs CRVS Comparison

MAGN vs CRVS Comparison

Compare MAGN & CRVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MAGN
  • CRVS
  • Stock Information
  • Founded
  • MAGN 1864
  • CRVS 2014
  • Country
  • MAGN United States
  • CRVS United States
  • Employees
  • MAGN N/A
  • CRVS N/A
  • Industry
  • MAGN Paper
  • CRVS Biotechnology: Pharmaceutical Preparations
  • Sector
  • MAGN Basic Materials
  • CRVS Health Care
  • Exchange
  • MAGN Nasdaq
  • CRVS Nasdaq
  • Market Cap
  • MAGN 416.2M
  • CRVS 459.0M
  • IPO Year
  • MAGN N/A
  • CRVS 2016
  • Fundamental
  • Price
  • MAGN $9.52
  • CRVS $7.32
  • Analyst Decision
  • MAGN Hold
  • CRVS Strong Buy
  • Analyst Count
  • MAGN 1
  • CRVS 4
  • Target Price
  • MAGN $12.00
  • CRVS $13.75
  • AVG Volume (30 Days)
  • MAGN 843.1K
  • CRVS 1.0M
  • Earning Date
  • MAGN 11-15-2025
  • CRVS 11-11-2025
  • Dividend Yield
  • MAGN N/A
  • CRVS N/A
  • EPS Growth
  • MAGN N/A
  • CRVS N/A
  • EPS
  • MAGN N/A
  • CRVS N/A
  • Revenue
  • MAGN $2,919,000,000.00
  • CRVS N/A
  • Revenue This Year
  • MAGN $49.20
  • CRVS N/A
  • Revenue Next Year
  • MAGN $5.03
  • CRVS N/A
  • P/E Ratio
  • MAGN N/A
  • CRVS N/A
  • Revenue Growth
  • MAGN 34.21
  • CRVS N/A
  • 52 Week Low
  • MAGN $8.93
  • CRVS $2.54
  • 52 Week High
  • MAGN $26.78
  • CRVS $10.00
  • Technical
  • Relative Strength Index (RSI)
  • MAGN 39.47
  • CRVS 59.79
  • Support Level
  • MAGN $9.23
  • CRVS $6.81
  • Resistance Level
  • MAGN $10.00
  • CRVS $7.98
  • Average True Range (ATR)
  • MAGN 0.57
  • CRVS 0.54
  • MACD
  • MAGN -0.05
  • CRVS -0.05
  • Stochastic Oscillator
  • MAGN 19.84
  • CRVS 72.33

About MAGN Magnera Corporation Common Stock

Magnera Corp formerly Glatfelter Corporation manufactures and sells a variety of paper and fiber products. The company's reportable segments are; Composite Fibers, Spunlace. and Airlaid Materials. The Airlaid Materials segment which is also its key revenue generating segment, is a supplier of cellulose-based airlaid nonwoven materials used to manufacture consumer products for end-user markets. The Airlaid Materials segment produces materials used in feminine hygiene, specialty wipes, tabletop, home care, and other consumables. Geographically, the company derives majority of its revenue from Americas and rest from Europe, Middle East, Africa and Asia Pacific markets.

About CRVS Corvus Pharmaceuticals Inc.

Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).

Share on Social Networks: